Famotidine

CAS No. 76824-35-6

Famotidine ( MK-208; YM-11170 )

Catalog No. M15908 CAS No. 76824-35-6

Famotidine is a competitive histamine H2-receptor antagonist.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 In Stock
25MG 59 In Stock
50MG 72 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Famotidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Famotidine is a competitive histamine H2-receptor antagonist.
  • Description
    Famotidine is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
  • Synonyms
    MK-208; YM-11170
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H2 receptor
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    76824-35-6
  • Formula Weight
    337.45
  • Molecular Formula
    C8H15N7O2S3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 67 mg/mL (198.54 mM)
  • SMILES
    N/C(N)=N\C1=NC(CSCC/C(N)=N/S(=O)(N)=O)=CS1
  • Chemical Name
    (Z)-3-(((2-((diaminomethylene)amino)thiazol-4-yl)methyl)thio)-N'-sulfamoylpropanimidamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Takahashi HK, et al. Mol Pharmacol. 2006 Aug;70(2):450-3.
molnova catalog
related products
  • Dimethindene maleate

    Dimethindene maleate is a histamine H1 antagonist and can be used in studies about the treatment of hypersensitivity reactions, pruritus and rhinitis.

  • Pitolisant oxalate

    A potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM; no effect on H1, H2, H4 receptors (IC50>10 uM).

  • Ciproxifan maleate

    Ciproxifan maleate(FUB-359 maleate) is a highly potent and selective histamin H3-receptor antagonist with IC50 of 9.2 nM, with low apparent affinity at other receptor subtypes.